|
1
|
Chen R, Alvero AB, Silasi DA, Steffensen
KD and Mor G: Cancers take their Toll - the function and regulation
of Toll-like receptors in cancer. Oncogene. 27:225–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hazeki K, Uehara M, Nigorikawa K and
Hazeki O: PIKfyve regulates the endosomal localization of CpG
oligodeoxynucleotides to elicit TLR9-dependent cellular responses.
PLoS One. 8:e738942013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmausser B, Andrulis M, Endrich S,
Muller-Hermelink HK and Eck M: Toll-like receptors TLR4, TLR5 and
TLR9 on gastric carcinoma cells: an implication for interaction
with Helicobacter pylori. Int J Med Microbiol. 295:179–185.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL
and Xu L: Functional expression of TLR9 is associated to the
metastatic potential of human lung cancer cell: functional active
role of TLR9 on tumor metastasis. Cancer Biol Ther. 6:1704–1709.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang YJ, Wu MS, Lin JT and Chen CC:
Helicobacter pylori-induced invasion and angiogenesis of
gastric cells is mediated by cyclooxygenase-2 induction through
TLR2/TLR9 and promoter regulation. J Immunol. 175:8242–8252. 2005.
View Article : Google Scholar
|
|
6
|
Li QL, Kim HR, Kim WJ, et al:
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation
is associated with lung cancer. Biochem Biophys Res Commun.
314:223–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kato N, Tamura G, Fukase M, Shibuya H and
Motoyama T: Hypermethylation of the RUNX3 gene promoter in
testicular yolk sac tumor of infants. Am J Pathol. 163:387–391.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y, Gao J, Su Z, et al: Downregulation
of Hlx closely related to the decreased expressions of T-bet and
Runx3 in patients with gastric cancer may be associated with a
pathological event leading to the imbalance of Th1/Th2. Clin Dev
Immunol. 2012:9498212012.
|
|
9
|
Kang KA, Kim KC, Bae SC and Hyun JW:
Oxidative stress induces proliferation of colorectal cancer cells
by inhibiting RUNX3 and activating the Akt signaling pathway. Int J
Oncol. 43:1511–1516. 2013.PubMed/NCBI
|
|
10
|
Li M, Tan SY, Zhang J and You HX: Effects
of paeonol on intracellular calcium concentration and expression of
RUNX3 in LoVo human colon cancer cells. Mol Med Rep. 7:1425–1430.
2013.PubMed/NCBI
|
|
11
|
Lim J, Duong T, Do N, Do P, Kim J, Kim H,
El-Rifai W, Ruley HE and Jo D: Antitumor activity of cell-permeable
RUNX3 protein in gastric cancer cells. Clin Cancer Res. 19:680–690.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito K: Tumor suppressive functions of
RUNX3 in gastric carcinogenesis. J Jpn Biochem Soc. 84:278–282.
2012.(In Japanese).
|
|
13
|
Yang P, Qiu G, Wang S, Su Z, Chen J, Wang
S, Kong F, Lu L, Ezaki T and Xu H: The mutations of Th1
cell-specific T-box transcription factor may be associated with a
predominant Th2 phenotype in gastric cancers. Int J Immunogenet.
37:111–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yano T, Ito K, Fukamachi H, Chi XZ, Wee
HJ, Inoue K, Ida H, Bouillet P, Strasser A, Bae SC and Ito Y: The
RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells
undergoing transforming growth factor beta-induced apoptosis. Mol
Cell Biol. 26:4474–4488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fainaru O, Woolf E, Lotem J, Yarmus M,
Brenner O, Goldenberg D, Negreanu V, Bernstein Y, Levanon D, Jung S
and Groner Y: Runx3 regulates mouse TGF-beta-mediated dendritic
cell function and its absence results in airway inflammation. EMBO
J. 23:969–979. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Kleeff J, Guweidhi A, Esposito I,
Berberat PO, Giese T, Buchler MW and Friess H: RUNX3 expression in
primary and metastatic pancreatic cancer. J Clin Pathol.
57:294–299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miyazono K, Suzuki H and Imamura T:
Regulation of TGF-beta signaling and its roles in progression of
tumors. Cancer Sci. 94:230–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Djuretic IM, Levanon D, Negreanu V, Groner
Y, Rao A and Ansel KM: Transcription factors T-bet and Runx3
cooperate to activate Ifng and silence Il4 in T helper type 1
cells. Nat Immunol. 8:145–153. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu N, Ohnishi N, Ni L, Akira S and Bacon
KB: CpG directly induces T-bet expression and inhibits IgG1 and IgE
switching in B cells. Nat Immunol. 4:687–693. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosa R, Damiano V, Formisano L, Nappi L,
Marciano R, Veneziani BM, De Placido S and Bianco R: Combination of
a Toll-like receptor 9 agonist with everolimus interferes with the
growth and angiogenic activity of renal cell carcinoma.
Oncoimmunology. 2:e251232013. View Article : Google Scholar : PubMed/NCBI
|
